首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2019年 8期 遗传性肝病的诊断 => 专家论坛 =>钠牛磺胆酸共转运多肽..
钠牛磺胆酸共转运多肽缺陷病的发病机制、临床表现及诊疗进展
Research advances in the pathogenesis, clinical manifestations, and diagnosis/treatment of sodium-taurocholate cotransporting polypeptide deficiency
文章发布日期:2019年07月05日  来源:  作者:宋元宗  点击次数:759次  下载次数:283次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:钠牛磺胆酸共转运多肽(NTCP)缺陷病是SLC10A1双等位基因突变导致的一种新的遗传性胆汁酸代谢病,在我国可能并不罕见。NTCP缺陷病以儿童期显著而持续性的高胆汁酸血症为主要临床特征,并可能参与新生儿高胆红素血症、婴儿早期胆汁淤积症和妊娠胆汁淤积症的形成。NTCP缺陷病目前缺乏特异性治疗手段,但通常预后良好。SLC10A1基因分析有助于该病患者及时确诊,同时避免不必要的检查和干预。
【Abstract】:Sodium-taurocholate cotransporting polypeptide (NTCP) deficiency is a new hereditary bile acid metabolic disease due to biallelic mutations of the SLC10A1 gene and is not rare in China. Marked and persistent hypercholanemia in childhood is the major clinical feature of NTCP deficiency, and this condition might be involved in the development of neonatal hyperbilirubinemia, cholestasis in early infancy, and cholestasis in pregnancy. At present, there lack specific therapies for NTCP deficiency, but such patients tend to have good prognosis. SLC10A1 gene detection may facilitate the timely and definite diagnosis of this disease and thus avoid unnecessary examinations and interventions.
【关键字】:代谢疾病; 钠牛磺胆酸共转运多肽; SLC10A1基因; 胆汁淤积
【Key words】:metabolic diseases; sodium-taurocholate cotransporting polypeptide; SLC10A1 gene; cholestasis
【引证本文】:SONG YZ. Research advances in the pathogenesis, clinical manifestations, and diagnosis/treatment of sodium taurocholate cotransporting polypeptide deficiency[J]. J Clin Hepatol, 2019, 35(8): 1690-1692. (in Chinese)
宋元宗. 钠牛磺胆酸共转运多肽缺陷病的发病机制、临床表现及诊疗进展[J]. 临床肝胆病杂志, 2019, 35(8): 1690-1692.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号